However, the potential for such studies exists, as CMs are known for their anti-inflammatory and protective effects on the cardiovascular system, which could be further explored using these genetically modified mouse models to understand their mechanisms of action in modulating IL-17A/IL-17RA pathways in cardiovascular diseases. Here, IL17RA is linked to cardiovascular disorder.